Literature DB >> 24096388

High-dimensional, massive sample-size Cox proportional hazards regression for survival analysis.

Sushil Mittal1, David Madigan, Randall S Burd, Marc A Suchard.   

Abstract

Survival analysis endures as an old, yet active research field with applications that spread across many domains. Continuing improvements in data acquisition techniques pose constant challenges in applying existing survival analysis methods to these emerging data sets. In this paper, we present tools for fitting regularized Cox survival analysis models on high-dimensional, massive sample-size (HDMSS) data using a variant of the cyclic coordinate descent optimization technique tailored for the sparsity that HDMSS data often present. Experiments on two real data examples demonstrate that efficient analyses of HDMSS data using these tools result in improved predictive performance and calibration.

Entities:  

Keywords:  Big data; Cox proportional hazards; Regularized regression; Survival analysis

Mesh:

Year:  2013        PMID: 24096388      PMCID: PMC3944969          DOI: 10.1093/biostatistics/kxt043

Source DB:  PubMed          Journal:  Biostatistics        ISSN: 1465-4644            Impact factor:   5.899


  15 in total

1.  Improved performance on high-dimensional survival data by application of Survival-SVM.

Authors:  V Van Belle; K Pelckmans; S Van Huffel; J A K Suykens
Journal:  Bioinformatics       Date:  2010-11-08       Impact factor: 6.937

2.  Gradient lasso for Cox proportional hazards model.

Authors:  Insuk Sohn; Jinseog Kim; Sin-Ho Jung; Changyi Park
Journal:  Bioinformatics       Date:  2009-05-15       Impact factor: 6.937

3.  Sparse kernel methods for high-dimensional survival data.

Authors:  Ludger Evers; Claudia-Martina Messow
Journal:  Bioinformatics       Date:  2008-05-30       Impact factor: 6.937

4.  L1 penalized estimation in the Cox proportional hazards model.

Authors:  Jelle J Goeman
Journal:  Biom J       Date:  2010-02       Impact factor: 2.207

Review 5.  Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.

Authors:  F E Harrell; K L Lee; D B Mark
Journal:  Stat Med       Date:  1996-02-28       Impact factor: 2.373

6.  A method for checking regression models in survival analysis based on the risk score.

Authors:  J K Grønnesby; O Borgan
Journal:  Lifetime Data Anal       Date:  1996       Impact factor: 1.588

7.  Gene expression profiling predicts clinical outcome of breast cancer.

Authors:  Laura J van 't Veer; Hongyue Dai; Marc J van de Vijver; Yudong D He; Augustinus A M Hart; Mao Mao; Hans L Peterse; Karin van der Kooy; Matthew J Marton; Anke T Witteveen; George J Schreiber; Ron M Kerkhoven; Chris Roberts; Peter S Linsley; René Bernards; Stephen H Friend
Journal:  Nature       Date:  2002-01-31       Impact factor: 49.962

8.  Evaluating the yield of medical tests.

Authors:  F E Harrell; R M Califf; D B Pryor; K L Lee; R A Rosati
Journal:  JAMA       Date:  1982-05-14       Impact factor: 56.272

9.  Regularization Paths for Generalized Linear Models via Coordinate Descent.

Authors:  Jerome Friedman; Trevor Hastie; Rob Tibshirani
Journal:  J Stat Softw       Date:  2010       Impact factor: 6.440

10.  Survival analysis with high-dimensional covariates: an application in microarray studies.

Authors:  David Engler; Yi Li
Journal:  Stat Appl Genet Mol Biol       Date:  2009-02-11
View more
  11 in total

1.  Efficient ℓ0 -norm feature selection based on augmented and penalized minimization.

Authors:  Xiang Li; Shanghong Xie; Donglin Zeng; Yuanjia Wang
Journal:  Stat Med       Date:  2017-10-30       Impact factor: 2.373

Review 2.  OPENMENDEL: a cooperative programming project for statistical genetics.

Authors:  Hua Zhou; Janet S Sinsheimer; Douglas M Bates; Benjamin B Chu; Christopher A German; Sarah S Ji; Kevin L Keys; Juhyun Kim; Seyoon Ko; Gordon D Mosher; Jeanette C Papp; Eric M Sobel; Jing Zhai; Jin J Zhou; Kenneth Lange
Journal:  Hum Genet       Date:  2019-03-26       Impact factor: 4.132

3.  Online Updating of Survival Analysis.

Authors:  Jing Wu; Ming-Hui Chen; Elizabeth D Schifano; Jun Yan
Journal:  J Comput Graph Stat       Date:  2021-03-08       Impact factor: 2.302

4.  Scalable Algorithms for Large Competing Risks Data.

Authors:  Eric S Kawaguchi; Jenny I Shen; Marc A Suchard; Gang Li
Journal:  J Comput Graph Stat       Date:  2020-12-11       Impact factor: 1.884

5.  A surrogate ℓ0 sparse Cox's regression with applications to sparse high-dimensional massive sample size time-to-event data.

Authors:  Eric S Kawaguchi; Marc A Suchard; Zhenqiu Liu; Gang Li
Journal:  Stat Med       Date:  2019-12-08       Impact factor: 2.497

6.  Extreme learning machine Cox model for high-dimensional survival analysis.

Authors:  Hong Wang; Gang Li
Journal:  Stat Med       Date:  2019-01-10       Impact factor: 2.497

7.  Using indication embeddings to represent patient health for drug safety studies.

Authors:  Rachel D Melamed
Journal:  JAMIA Open       Date:  2020-10-27

8.  Prognostic role and clinical significance of C-reactive protein-lymphocyte ratio in colorectal cancer.

Authors:  Yongsheng Meng; Chenyan Long; Xiaoliang Huang; Lihaoyun Huang; Lixian Liao; Weizhong Tang; Jungang Liu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

9.  Systematic assessment of pharmaceutical prescriptions in association with cancer risk: a method to conduct a population-wide medication-wide longitudinal study.

Authors:  Chirag J Patel; Jianguang Ji; Jan Sundquist; John P A Ioannidis; Kristina Sundquist
Journal:  Sci Rep       Date:  2016-08-10       Impact factor: 4.379

10.  Comparative effectiveness of canagliflozin, SGLT2 inhibitors and non-SGLT2 inhibitors on the risk of hospitalization for heart failure and amputation in patients with type 2 diabetes mellitus: A real-world meta-analysis of 4 observational databases (OBSERVE-4D).

Authors:  Patrick B Ryan; John B Buse; Martijn J Schuemie; Frank DeFalco; Zhong Yuan; Paul E Stang; Jesse A Berlin; Norman Rosenthal
Journal:  Diabetes Obes Metab       Date:  2018-06-25       Impact factor: 6.577

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.